A solid lipid coated calcium peroxide nanocarrier enables combined cancer chemo/chemodynamic therapy with O2/H2O2 self-sufficiency

The unfavorable factors in tumor microenvironment such as hypoxia and limited H2O2 levels greatly impede the anticancer efficacy of chemotherapy and chemodynamic therapy (CDT). To address these issues and achieve O2/H2O2-sufficient chemo/chemodynamic combination therapy, we synthesized a solid lipid...

Full description

Saved in:
Bibliographic Details
Published in:Acta biomaterialia 2021-03, Vol.122, p.354-364
Main Authors: He, Chuanchuan, Zhang, Xiaojuan, Chen, Chen, Liu, Xiaoguang, Chen, Yan, Yan, Ruicong, Fan, Ting, Gai, Yongkang, Lee, Robert J., Ma, Xiang, Luo, Jun, Lu, Yao, Yang, Tan, Xiang, Guangya
Format: Article
Language:English
Subjects:
Anticancer properties
Aqueous environments
Biocompatibility
Calcium
Calcium peroxide
Cancer
Cancer therapies
Catalysts
Chemodynamic therapy
Chemotherapy
Doxorubicin
Fenton reactions
Hydrogen peroxide
Hydroxyl radicals
Hypoxia
Iron
Lipids
Nanoparticles
Tumor microenvironment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The unfavorable factors in tumor microenvironment such as hypoxia and limited H2O2 levels greatly impede the anticancer efficacy of chemotherapy and chemodynamic therapy (CDT). To address these issues and achieve O2/H2O2-sufficient chemo/chemodynamic combination therapy, we synthesized a solid lipid monostearin coated calcium peroxide (CaO2) nanocarrier for the co-delivery of a chemotherapeutic drug doxorubicin (DOX) and a biocompatible Fenton catalyst iron-oleate complex. Specifically, the solid lipid shells of nanoparticles could disintegrate in lipase-overexpressed cancer cells to release iron-oleate and expose CaO2 cores. Afterwards, the uncovered CaO2 responded to the acidic aqueous environment within cancer cells, leading to the release of DOX molecules and generation of H2O2. Based on Fenton reactions, Fe3+ liberated from iron-oleate reacted with H2O2 to produce O2 for hypoxia-relieved chemotherapy, and Fe2+ for the catalytic generation of hydroxyl radical to initiate CDT. Both treatments synergistically contribute to the enhanced antitumor outcomes. [Display omitted]
ISSN:1742-7061
1878-7568
DOI:10.1016/j.actbio.2020.12.036